| Literature DB >> 14696568 |
.
Abstract
Atazanavir (Reyataz) is a protease inhibitor that received FDA approval in June 2003. Other approved drugs in this class include amprenavir, indinavir, Kaletra (ritonavir + lopinavir), nelfinavir, ritonavir and saquinavir.Entities:
Mesh：
Substances：
Year: 2003 PMID： 14696568
Source DB: PubMed Journal: Proj Inf Perspect ISSN： 1058-7454